Home » Newsletters » BioWorld Science

BioWorld Science

April 10, 2012

View Archived Issues

New agent for liver disorders patented by Norgine Europe

First-in-class cancer immunotherapy well tolerated in phase I trial

Novel solute carrier family 22 member 12 inhibitors designed

Bristol-Myers Squibb presents novel HIV integrase inhibitors

Taiho Pharmaceutical reports new H-PGDS inhibitors

New protein kinase inhibitors disclosed by Bayer Schering Pharma

Cell-based gene therapy is well tolerated in phase I study

CSA-131 active against Gram-negative bacteria

ARMOR1 trial assesses safety of galeterone in prostate cancer

Amgen presents first preclinical data on novel anticancer drug

New data support potential of Cell-in-a-Box technology

Novel anticancer nanomedicine shows promise in clinical trial

DARPin-based VEGF inhibitor completes phase IIa trial

Muscular Dystrophy Association awards grant to Catabasis Pharmaceuticals

Sanofi and Alfresa Pharma launch vigabatrin collaboration

Stroke biomarker license granted to Randox

Spectrum Pharmaceuticals announces acquisition

Phase III results reported for apaziquone

Amorfix establishes proof of concept for lead tumor-specific antibody

FDA approves adjunct radioactive diagnostic for Alzheimer's disease

FDA advisory committee issues recommendation on Astellas' mirabegron

Preclinical studies demonstrate small molecule's efficacy to treat anterior uveitis

Phase I/II trial begins evaluating Syndax's entinostat with lapatinib in metastatic breast cancer

Winston Pharmaceuticals receives grant to develop civamide nasal solution

Pacira Pharmaceuticals launches Exparel in U.S.

Next-generation drug-eluting stent approved in Japan to treat coronary artery disease

Pharmos reports promising data from ongoing phase IIa trial of levotofisopam

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...